Log in

NASDAQ:ICUI - ICU Medical Stock Price, Forecast & News

$185.24
+1.02 (+0.55 %)
(As of 12/8/2019 12:04 PM ET)
Today's Range
$184.80
Now: $185.24
$187.35
50-Day Range
$154.85
MA: $172.59
$189.51
52-Week Range
$148.89
Now: $185.24
$259.72
Volume128,941 shs
Average Volume259,477 shs
Market Capitalization$3.83 billion
P/E Ratio24.03
Dividend YieldN/A
Beta0.92
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.40 billion
Cash Flow$11.87 per share
Book Value$61.67 per share

Profitability

Net Income$28.79 million

Miscellaneous

Employees8,100
Market Cap$3.83 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.


ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) issued its quarterly earnings results on Monday, November, 11th. The medical instruments supplier reported $1.65 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.03. The medical instruments supplier had revenue of $307.47 million for the quarter, compared to analysts' expectations of $297.83 million. ICU Medical had a net margin of 5.66% and a return on equity of 12.13%. The business's quarterly revenue was down 6.0% on a year-over-year basis. During the same period last year, the business earned $1.85 earnings per share. View ICU Medical's Earnings History.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for ICU Medical.

What price target have analysts set for ICUI?

1 Wall Street analysts have issued twelve-month price targets for ICU Medical's shares. Their forecasts range from $203.00 to $203.00. On average, they expect ICU Medical's stock price to reach $203.00 in the next year. This suggests a possible upside of 9.6% from the stock's current price. View Analyst Price Targets for ICU Medical.

What is the consensus analysts' recommendation for ICU Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ICU Medical.

Has ICU Medical been receiving favorable news coverage?

News headlines about ICUI stock have trended very negative this week, InfoTrie reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ICU Medical earned a media sentiment score of -3.1 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an impact on the company's share price in the immediate future. View News Stories for ICU Medical.

Are investors shorting ICU Medical?

ICU Medical saw a increase in short interest in October. As of October 15th, there was short interest totalling 958,300 shares, an increase of 25.6% from the September 15th total of 763,200 shares. Based on an average trading volume of 250,900 shares, the days-to-cover ratio is presently 3.8 days. Currently, 5.0% of the company's shares are sold short. View ICU Medical's Current Options Chain.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton Dickinson and (BDX), CA (CA), BlackRock (BLK), Endologix (ELGX), Alibaba Group (BABA), Chipotle Mexican Grill (CMG), UnitedHealth Group (UNH), GW Pharmaceuticals PLC- (GWPH), Netflix (NFLX) and NVIDIA (NVDA).

Who are ICU Medical's key executives?

ICU Medical's management team includes the folowing people:
  • Mr. Vivek Jain, Chairman & CEO (Age 47)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 56)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 51)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 44)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 61)

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (2.46%), Findlay Park Partners LLP (2.18%), GW&K Investment Management LLC (1.68%), Point72 Asset Management L.P. (1.08%), Eagle Asset Management Inc. (0.55%) and AMI Asset Management Corp (0.35%). Company insiders that own ICU Medical stock include Alison D Burcar, Christian B Voigtlander, Daniel Woolson, George A Lopez, Joseph R Saucedo, Kevin J Mcgrody, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall and Virginia Ruth Sanzone. View Institutional Ownership Trends for ICU Medical.

Which institutional investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC, Barclays PLC, Russell Investments Group Ltd., Scout Investments Inc., SG Americas Securities LLC, Oppenheimer Asset Management Inc., WCM Investment Management LLC and Envestnet Asset Management Inc.. Company insiders that have sold ICU Medical company stock in the last year include Christian B Voigtlander, George A Lopez, Kevin J Mcgrody, Robert S Swinney, Scott E Lamb and Virginia Ruth Sanzone. View Insider Buying and Selling for ICU Medical.

Which institutional investors are buying ICU Medical stock?

ICUI stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Findlay Park Partners LLP, State Street Corp, Tamarack Advisers LP, Kirr Marbach & Co. LLC IN, California Public Employees Retirement System, Voloridge Investment Management LLC and Chartwell Investment Partners LLC. View Insider Buying and Selling for ICU Medical.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $185.24.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $3.83 billion and generates $1.40 billion in revenue each year. The medical instruments supplier earns $28.79 million in net income (profit) each year or $7.71 on an earnings per share basis. ICU Medical employs 8,100 workers across the globe.View Additional Information About ICU Medical.

What is ICU Medical's official website?

The official website for ICU Medical is http://www.icumed.com/.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]


MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  323 (Vote Outperform)
Underperform Votes:  328 (Vote Underperform)
Total Votes:  651
MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel